Literature DB >> 8553540

Immune effector mechanisms required for protection to rabies virus.

Z Q Xiang1, B B Knowles, J W McCarrick, H C Ertl.   

Abstract

Genetically engineered mice with targeted mutations in genes encoding immunologically relevant molecules were used to elucidate the role of different immune effector mechanisms in protection against a rabies virus (RV) infection. In vaccinated animals challenged with a highly virulent strain of RV, antibodies were crucial in protection. In naive mice challenged with an attenuated strain of the virus that does not cause disease in adult fully immunocompetent mice but kills RAG mice that lack functionally active T and B cells, different immune effector mechanisms were shown to suffice for protection.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8553540     DOI: 10.1006/viro.1995.0049

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  13 in total

Review 1.  The role of immune responses in the pathogenesis of rabies.

Authors:  D Craig Hooper
Journal:  J Neurovirol       Date:  2005-02       Impact factor: 2.643

Review 2.  Immunity to retroviral infection: the Friend virus model.

Authors:  K J Hasenkrug; B Chesebro
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-22       Impact factor: 11.205

3.  Importance of B cells, but not specific antibodies, in primary and secondary protective immunity to the intracellular bacterium Francisella tularensis live vaccine strain.

Authors:  K L Elkins; C M Bosio; T R Rhinehart-Jones
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

4.  Effect of passive immunization or maternally transferred immunity on the antibody response to a genetic vaccine to rabies virus.

Authors:  Y Wang; Z Xiang; S Pasquini; H C Ertl
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

5.  The use of an E1-deleted, replication-defective adenovirus recombinant expressing the rabies virus glycoprotein for early vaccination of mice against rabies virus.

Authors:  Y Wang; Z Xiang; S Pasquini; H C Ertl
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

6.  Oral vaccination of mice with adenoviral vectors is not impaired by preexisting immunity to the vaccine carrier.

Authors:  Z Q Xiang; G P Gao; A Reyes-Sandoval; Y Li; J M Wilson; H C J Ertl
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

7.  Novel, chimpanzee serotype 68-based adenoviral vaccine carrier for induction of antibodies to a transgene product.

Authors:  Zhiquan Xiang; Guangping Gao; Arturo Reyes-Sandoval; Christopher J Cohen; Yan Li; Jeffrey M Bergelson; James M Wilson; Hildegund C J Ertl
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

8.  Protein profiling of human nonpigmented ciliary epithelium cell secretome: the differentiation factors characterization for retinal ganglion cell line.

Authors:  Ming-Hui Yang; Raghu R Krishnamoorthy; Shiang-Bin Jong; Pei-Yu Chu; Yuan-Han Yang; Wen-Cheng Chen; Sharon Chia-Ju Chen; Adnan Dibas; Thomas Yorio; Tze-Wen Chung; Yu-Chang Tyan
Journal:  J Biomed Biotechnol       Date:  2011-08-10

Review 9.  The influence of delivery vectors on HIV vaccine efficacy.

Authors:  Beatrice O Ondondo
Journal:  Front Microbiol       Date:  2014-08-22       Impact factor: 5.640

10.  Novel vaccines to human rabies.

Authors:  Hildegund C J Ertl
Journal:  PLoS Negl Trop Dis       Date:  2009-09-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.